Wang et al. [137] showed that the interaction between DVL1 and CtBP2 modulates the Wnt/β-catenin signaling pathway, influencing cell proliferation and drug sensitivity in NSCLC. Here, CTBP2 is linked to non-small cell lung carcinoma.